Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Hans Biomed Corporation
FDA Inspection
•Hans Biomed Corporation•August 25, 2023

Hans Biomed Corporation – FDA Inspection, Aug 25, 2023

Record Details

This FDA Inspection record concerns Hans Biomed Corporation, with an inspection on August 25, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Hans Biomed Corporation
Inspection Date
August 25, 2023
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
Person
  • Emily B. Camire (Issuing Officer)
View Company Profile

ID · c9aabe20-af7a-4aed-ab22-36696d9695f0

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1216052
FDA center
Biologics
Project area
Human Cellular, Tissue, and Gene Therapies
Outcome
Form 483 issued

FDA Citations

12
  1. 21 CFR 1271.195(d)Documentation not maintained
  2. 21 CFR 1271.200(e)Documentation of maintenance and cleaning
  3. 21 CFR 1271.195(c)Monitoring--cross contamination, exposure to CD
  4. 21 CFR 1271.195(a)(1)Temperature and humidity controls
  5. 21 CFR 1271.270(a)Records incomplete
  6. 21 CFR 1271.210(a)Use prior to verification
  7. 21 CFR 1271.195(a)(1)Temperature and humidity controls
  8. 21 CFR 1271.195(c)Monitoring--cross contamination, exposure to CD
  9. 21 CFR 1271.195(d)Documentation not maintained
  10. 21 CFR 1271.200(e)Documentation of maintenance and cleaning

Showing 10 of 12 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Hans Biomed Corporation

7
DateClassificationOfficeProject area
September 12, 2025VAIOffice of Inspections and InvestigationsHuman Cellular, Tissue, and Gene Therapies
April 5, 2019NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
March 31, 2016VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
June 3, 2014VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
August 29, 2013VAICenter for Devices and Radiological HealthCompliance: Devices
View all 7 other inspections on the company page
Other documents for Hans Biomed Corporation
  • FDA Inspection 1282278 - 2025-09-12
  • FDA Inspection 1091073 - 2019-04-05
  • FDA Inspection 966652 - 2016-03-31
  • FDA Inspection 893493 - 2014-06-03
  • FDA Inspection 848720 - 2013-08-29

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hans Biomed Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.